157 related articles for article (PubMed ID: 32845308)
21. Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens.
Scalfaro C; Iacobino A; Nardis C; Franciosa G
FEMS Microbiol Lett; 2017 Apr; 364(7):. PubMed ID: 28369512
[TBL] [Abstract][Full Text] [Related]
22. Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection.
Rossoni RD; Fuchs BB; de Barros PP; Velloso MD; Jorge AO; Junqueira JC; Mylonakis E
PLoS One; 2017; 12(3):e0173332. PubMed ID: 28267809
[TBL] [Abstract][Full Text] [Related]
23. Live and heat-killed Lactobacillus reuteri reduce alveolar bone loss on induced periodontitis in rats.
Moraes RM; Lescura CM; Milhan NVM; Ribeiro JL; Silva FA; Anbinder AL
Arch Oral Biol; 2020 Nov; 119():104894. PubMed ID: 32950917
[TBL] [Abstract][Full Text] [Related]
24. Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model.
Moman R; O'Neill CA; Ledder RG; Cheesapcharoen T; McBain AJ
Front Microbiol; 2020; 11():999. PubMed ID: 32612578
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.
Sánchez MC; Ribeiro-Vidal H; Esteban-Fernández A; Bartolomé B; Figuero E; Moreno-Arribas MV; Sanz M; Herrera D
BMC Complement Altern Med; 2019 Jun; 19(1):145. PubMed ID: 31226983
[TBL] [Abstract][Full Text] [Related]
26. Comparative virulence of periodontopathogens in a mouse abscess model.
Ebersole JL; Kesavalu L; Schneider SL; Machen RL; Holt SC
Oral Dis; 1995 Sep; 1(3):115-28. PubMed ID: 8705817
[TBL] [Abstract][Full Text] [Related]
27. Pericardial empyema due to Actinomyces israelii, Aggregatibacter actinomycetemcomitans, and Fusobacterium nucleatum.
Reisinger A; Matzkies LM; Eller P; Fruhwald F; Krause R
Pol Arch Intern Med; 2019 Oct; 129(10):714-715. PubMed ID: 31316043
[No Abstract] [Full Text] [Related]
28. Antagonistic interactions among Fusobacterium nucleatum and Prevotella intermedia with oral lactobacilli.
Testa MM; Ruiz de Valladares R; Benito de Cardenas IL
Res Microbiol; 2003 Dec; 154(10):669-75. PubMed ID: 14643404
[TBL] [Abstract][Full Text] [Related]
29. Probiotic Monotherapy with
Salinas-Azuceno C; Martínez-Hernández M; Maldonado-Noriega JI; Rodríguez-Hernández AP; Ximenez-Fyvie LA
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805491
[TBL] [Abstract][Full Text] [Related]
30. Comparison of culture and real-time PCR for detection and quantification of five putative periodontopathogenic bacteria in subgingival plaque samples.
Jervøe-Storm PM; Koltzscher M; Falk W; Dörfler A; Jepsen S
J Clin Periodontol; 2005 Jul; 32(7):778-83. PubMed ID: 15966886
[TBL] [Abstract][Full Text] [Related]
31. Mixed infection involving Actinomyces, Aggregatibacter, and Fusobacterium species presenting as perispinal tumor.
Ghafghaichi L; Troy S; Budvytiene I; Banaei N; Baron EJ
Anaerobe; 2010 Apr; 16(2):174-8. PubMed ID: 19628046
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Papillon-Lefèvre syndrome periodontitis.
Pacheco JJ; Coelho C; Salazar F; Contreras A; Slots J; Velazco CH
J Clin Periodontol; 2002 Apr; 29(4):370-4. PubMed ID: 11966936
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative activity of Actinobacillus (Haemophilus) actinomycetemcomitans and Fusobacterium nucleatum in peripheral blood mononuclear cells.
do Vale CH; de Oliveira Fraga LA; Costa AS; Tavares CA; Martins-Filho OA; de Macedo Farias L; Roque de Carvalho MA
Res Microbiol; 2004 Nov; 155(9):731-40. PubMed ID: 15501650
[TBL] [Abstract][Full Text] [Related]
34. Actinobacillus actinomycetemcomitans serotype b lipopolysaccharide mediates coaggregation with Fusobacterium nucleatum.
Rosen G; Nisimov I; Helcer M; Sela MN
Infect Immun; 2003 Jun; 71(6):3652-6. PubMed ID: 12761156
[TBL] [Abstract][Full Text] [Related]
35. Quantitation of biofilm and planktonic life forms of coexisting periodontal species.
Karched M; Bhardwaj RG; Inbamani A; Asikainen S
Anaerobe; 2015 Oct; 35(Pt A):13-20. PubMed ID: 25926392
[TBL] [Abstract][Full Text] [Related]
36. Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice.
Sun MC; Zhang FC; Yin X; Cheng BJ; Zhao CH; Wang YL; Zhang ZZ; Hao HW; Zhang TH; Ye HQ
J Food Sci; 2018 Oct; 83(10):2645-2652. PubMed ID: 30216448
[TBL] [Abstract][Full Text] [Related]
37. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
38. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
39. Salivary microbiota levels in relation to periodontal status, experience of caries and miswak use in Sudanese adults.
Darout IA; Albandar JM; Skaug N; Ali RW
J Clin Periodontol; 2002 May; 29(5):411-20. PubMed ID: 12060423
[TBL] [Abstract][Full Text] [Related]
40. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion.
Prince T; McBain AJ; O'Neill CA
Appl Environ Microbiol; 2012 Aug; 78(15):5119-26. PubMed ID: 22582077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
